The transformation suppressor gene, programmed cell death gene 4 (Pdcd4), inhibits tumor-promoter-mediated transformation of mouse keratinocytes and has been implicated as a tumor suppressor gene in the development of human cancer. The Pdcd4 protein interacts with translation initiation factors eIF4A and eIF4G and binds to RNA, suggesting that it might be involved in regulating protein translation or other aspects of RNA metabolism. To study the function of Pdcd4 in more detail, we have downregulated Pdcd4 expression in HeLa cells by stable expression of shRNA. We have found that diminished Pdcd4 expression leads to increased expression of p21(Waf1/Cip1) and several other p53-regulated genes. Reporter gene studies demonstrate that Pdcd4 interferes with the activation of p53-responsive promoters genes by p53. Pdcd4 knockdown cells show decreased apoptosis and increased survival after UV irradiation. Taken together, our observations suggest a model in which low Pdcd4 expression after DNA damage favors the survival of cells, which would be eliminated by apoptosis under normal levels of Pdcd4 expression. Our results provide the first evidence that Pdcd4 is important role in the DNA-damage response and suggest that low levels of Pdcd4 expression observed in certain tumor cells contribute to tumorigenesis by affecting the fate of DNA-damaged cells.
Introduction
The programmed cell death gene 4 (Pdcd4) (also known as MA-3, TIS, H731 and DUG) was originally identified in a screen for genes activated during apoptosis (Shibahara et al., 1995;  for reviews see Lankat-Buttgereit and Go¨ke, 2003; Young et al., 2003) . Subsequent work identified Pdcd4 as a transformation suppressor gene in a mouse keratinocyte model of tumor promotion, in which high levels of Pdcd4 rendered cells resistant to transformation by the tumor-promoter 12-O-tetradecanoyl-phorbol-13-acetate (TPA) (Cmarik et al., 1999) . Further work showed that the expression of Pdcd4 is reduced in cells derived from different types of human tumors (Chen et al., 2003; Jansen et al., 2004; Zhang et al., 2006) and loss of Pdcd4 expression has been strongly implicated in the development and progression of several kinds of human cancer (Chen et al., 2003; Afonja et al., 2004; Zhang et al., 2006; Mudduluru et al., 2007; Wen et al., 2007; Wang et al., 2008) . Recently, Pdcd4 has been shown to suppress tumor development in a mouse model of skin carcinogenesis (Jansen et al., 2005) , whereas Pdcd4 knockout mice were found to develop spontaneous lymphomas (Hilliard et al., 2006) . Together, these observations have suggested that Pdcd4 is a novel tumor suppressor gene.
The Pdcd4 protein is a predominantly nuclear protein that is able to shuttle to the cytoplasm under conditions of serum depletion (Bo¨hm et al., 2003) . Recently, phosphorylation by Akt kinase has been implicated in the nuclear translocation of Pdcd4 (Palamarchuk et al., 2005) . The Pdcd4 protein contains two copies of a highly conserved domain (referred to as MA-3 domain) and an N-terminal region that binds RNA in vitro (Bo¨hm et al., 2003) . MA-3 domains are thought to be involved in protein-protein interactions and the tertiary structure of one of the two Pdcd4 MA-3 domains has been recently solved (LaRonde-LeBlanc et al., 2007; Waters et al., 2007) . Pdcd4 has been shown to interact with the eukaryotic translation initiation factor eIF4A via its C-terminal MA-3 domain (Go¨ke et al., 2002; Yang et al., 2003a Yang et al., , 2004 Waters et al., 2006 Waters et al., , 2007 LaRondeLeBlanc et al., 2007) . eIF4A is a member of the DEAD box RNA helicase family (Linder et al., 1989) and catalyses the unwinding of stable secondary structure in the 5 0 -untranslated region (UTR) of mRNAs, allowing the recruitment of the 40S ribosomal subunit to the 5 0 cap of mRNA (Hershey and Merrick, 2000) . The inherent helicase activity of eIF4A is strongly stimulated by binding to the scaffold protein eIF4G to form part of the eIF4F complex, which also includes the cap-binding protein eIF4E (Rozen et al., 1990) . The interaction with Pdcd4 inhibits the helicase activity of eIF4A, suggesting that Pdcd4 inhibits the translation of mRNAs with 5 0 -structured UTRs. Recently, mitogenactivated signaling via the phosphoinositide-3 kinase Akt-mammalian target of rapamycin pathway has been shown to target cytoplasmic Pdcd4 for phosphorylation by S6 kinase resulting in rapid degradation of the protein (Dorrello et al., 2006) . This suggests that the translational inhibitory role of Pdcd4 might be particularly important in nondividing cells.
Recently, an additional role of Pdcd4 in the transcription of specific genes was demonstrated. Pdcd4 has been shown to inhibit the activation of AP1-dependent promoters by c-Jun, an observation which might explain the inhibition of TPA-induced keratinocyte transformation by Pdcd4 (Yang et al., 1990 (Yang et al., , 2001 (Yang et al., , 2003b . Several mechanisms appear to be responsible for the inhibition of c-Jun transactivation activity by Pdcd4. Pdcd4 has been shown to interact with c-Jun and thereby to interfere with the phosphorylation of c-Jun by the Jun N-terminal kinase (JNK) and the cooperation of c-Jun with the coactivator p300/creb-binding protein (CBP) (Bitomsky et al., 2004) . In addition, Pdcd4 downmodulates the transcription of the gene encoding the protein kinase MEKK1, which acts as an upstream component of the JNK-signaling pathway (Yang et al., 2006) . Together, these effects lead to inhibition of c-Jun activity and downregulation of AP1-responsive promoters by Pdcd4. The fact that many of the genes regulated by AP-1 are involved in aspects of cell motility and tumor cell invasion (reviewed in Ozanne et al., 2007) suggests that decreased expression of Pdcd4 might affect the tumor development by altering the mobility and invasiveness of the tumor cells. In accordance with this idea it has been shown that enforced expression of Pdcd4 in the metastatic colon carcinoma cell line RKO suppresses the invasive phenotype of the cells (Yang et al., 2006) .
To obtain further insight into the function of Pdcd4, we have used Pdcd4-specific siRNAs to generate stable clones of HeLa cells with reduced levels of Pdcd4. The analysis of these clones shows that the downregulation of Pdcd4 activates the p21(Waf1/Cip1) gene and of two other p53-regulated genes, Gadd45a and Dap kinase (Fornace et al., 1988; Martoriati et al., 2005) . Furthermore, we found that Pdcd4 diminishes the activation of a p21(Waf1/Cip1) reporter gene by p53. HeLa cell clones with decreased levels of Pdcd4 exhibit reduced rates of apoptosis and increased survival after ultraviolet (UV)-induced DNA damage. Taken together, our results suggest that low or absent expression of Pdcd4 may contribute to tumor development by diminishing the ability of cells with damaged DNA to undergo apoptosis thereby favoring their survival.
Results
siRNA-mediated knockdown of Pdcd4 causes upregulation of p21(Waf1/Cip1) expression To generate cells having reduced Pdcd4 expression, we first identified siRNAs that were effective in downregulating Pdcd4 expression. Figure 1a shows the results of transfecting HeLa cells with two Pdcd4-specific siRNAs and with a nonspecific control siRNA. It is apparent that the amounts of Pdcd4 protein as well as of Pdcd4 mRNA were efficiently downregulated after 48 h by the Pdcd4-specific siRNAs but not by the control siRNA. We then generated expression plasmids for the same Pdcd4-specific siRNAs using the pTER vector (van de Wetering et al., 2003) , followed by transfection of the plasmids into HeLa cells and selection of stable transfectants. Stably transfected cell clones were initially screened for the level of Pdcd4 expression and two clones (designated as K11 and 12) that showed reduced expression of Pdcd4 were selected for further analysis. The western blot shown in Figure 1b confirmed that both clones had substantially reduced levels of Pdcd4.
Previous work had identified p21(Waf1/Cip1) as a potential target for Pdcd4 (Go¨ke et al., 2004) . To investigate whether knockdown of Pdcd4 had an effect on p21(Waf1/Cip1) expression, we analysed both knockdown clones by western blotting using p21(Waf1/Cip1)-specific antibodies. The levels of p21(Waf1/Cip1) were increased in both clones siRNA-mediated knockdown of Pdcd4 expression N Bitomsky et al ( Figure 2a ). The expression of the p53 protein, a key regulator of the p21(Waf1/Cip1) gene, was only very slightly affected in the stable knockdown clones. Stable transfectants that had been transfected with the empty siRNA-expression vector did not show increased expression of p21(Waf1/Cip1) (data not shown), indicating that the selection procedure per se was not responsible for the upregulation of p21/Waf1/Cip1). Our observation that downregulation of Pdcd4 expression leads to increased expression of p21(Waf1/Cip1) was somewhat surprising since Go¨ke et al. (2004) have observed that overexpression of Pdcd4 in the human carcinoid cell line Bon-1 causes upregulation of p21(Waf1/Cip1). Either Pdcd4 exerts opposite effects on p21(Waf1/Cip1) in HeLa and Bon-1 cells or other as yet unknown reasons are responsible for this discrepant behavior.
In addition to analysing stable Pdcd4 knockdown clones, we performed transient knockdown experiments followed by western blot analysis of p21(Waf1/Cip1) expression. Figure 2b shows that the level of p21(Waf1/ Cip1) expression was increased by transfection of Pdcd4-specific siRNA but not by control siRNA. Western blotting with the Pdcd4-specific antiserum confirmed the knockdown of Pdcd4. Since the signals obtained with the p21(Waf1/Cip1)-specific antiserum were rather weak, we also treated the siRNA-transfected cells with the proteasome inhibitor MG132 to stabilize p21(Waf1/Cip1); this again showed that the expression of p21(Waf1/Cip1) was increased following knockdown of Pdcd4. There was no concomitant increase in the amount of p53, suggesting that the upregulation of p21(Waf1/Cip1) was not simply due to higher levels of p53. Taken together, the stable and transient transfections demonstrated that siRNA-mediated downregulation of Pdcd4 expression in HeLa cells is accompanied by increased p21(Waf1/Cip1) expression. A transient knockdown experiment was also performed using the HCT116 cell line (Figure 2c ). The knockdown of Pdcd4 was less efficient in HCT116 cells than in HeLa cells; nevertheless, a moderate increase of the amount of p21(Waf1/Cip1) was observed.
Knockdown of Pdcd4 is accompanied by increase levels of mRNA for p21(Waf1/Cip1) and certain other p53-regulated genes To explore the mechanism by which downregulation of Pdcd4 affects p21(Waf1/Cip1) expression, we examined the levels of p21(Waf1/Cip1) mRNA in the Pdcd4 knockdown clones and in control cells by northern blotting. Figure 3a shows that both clones had elevated siRNA-mediated knockdown of Pdcd4 expression N Bitomsky et al levels of p21(Waf1/Cip1) mRNA when compared to the parental HeLa cell line. This finding raised the possibility that downregulation of Pdcd4 might affect the expression of the p21(Waf1/Cip1) gene on the transcriptional level. One of the key regulators of p21(Waf1/Cip1) is the tumor-suppressor p53; we were therefore interested to examine possible effects of the downregulation of Pdcd4 on the p53 gene itself and on other p53 target genes. Figure 3a shows that there was no significant upregulation of p53 mRNA expression in the knockdown clones. As shown in Figure 3b , two other p53-regulated genes, Gadd45a and DAP kinase, were upregulated in the p53 knockdown clones compared to wild-type HeLa cells. However, not every p53-regulated gene was affected, as the expression of Puma mRNA was virtually indistinguishable between Pdcd4 knockdown and control cells.
Pdcd4 inhibits the transactivation potential of p53
The observation that the expression of several p53 target genes is increased following knockdown of Pdcd4, raised the possibility that Pdcd4 inhibits the activity of p53. To explore this possibility, we performed transient reporter gene assays using a reporter construct that encompasses p21(Waf1/Cip1) promoter sequences from À2326 to þ 16. This construct contains the p53-binding sites that have previously been mapped 2301 and 1394 bp upstream of the transcriptional start site of the gene (Gartel and Radhakrishnan, 2005) . Transfections were Polyadenylated RNA isolated from HeLa wild-type cells and the two stable Pdcd4 knockdown sublones (K11 and 12) was analysed by northern blotting using probes specific for the Pdcd4, p21(Waf1/Cip1), p53, Gadd45a, Dapk, Puma and ribosomal protein S17 genes. siRNA-mediated knockdown of Pdcd4 expression N Bitomsky et al performed in two different cell lines, using an expression vector for a green fluorescent protein (GFP)-p53 fusion protein to activate the promoter. As shown in Figures 4a and b , co-transfection of the reporter gene with the expression vector for the GFP-p53 fusion protein increased the activity of the promoter, as expected. Interestingly, additional transfection of a Pdcd4-expression vector diminished the activating effect of p53, consistent with the idea that Pdcd4 dampens p53-mediated transactivation. Similar results were obtained by using an artificial p53-dependent reporter gene (Figures 4c and d) . In this case, the stimulation of the reporter gene by p53 was stronger than that of the p21(Waf1/Cip1) promoter but again Pdcd4 diminished the effect of p53. The inhibitory effect of Pdcd4 on the activity of p53 was also demonstrated on the expression of the endogenous p21(Waf1/Cip1) gene (Figure 4e ). Transfection of HCT116 cells with an expression vector for p53 stimulated the expression of the endogenous p21(Waf1/Cip1), as expected. Consistent with the results of the reporter gene experiments, coexpression of Pdcd4 diminished the stimulation of p21(Waf1/Cip1) expression.
Pdcd4 interferes with the acetylation of p53
The experiments shown in Figure 4 demonstrated that Pdcd4 inhibits the activity of p53 without affecting the amount of p53 expressed in the transfected cells. We therefore considered the possibility that Pdcd4 affects the modification status of p53. Initial evidence that Pdcd4 might affect the acetylation of p53 was provided by experiments in which we compared the ability of the deacetylase inhibitor trichostatin A (TSA) stimulating p53 activity in the presence and absence of Pdcd4. Figure 5a shows that Pdcd4 expression significantly diminished the ability of TSA to stimulate p53 activity. This observation is consistent with the possibility that Pdcd4 suppresses the acetylation of p53. To address this possibility, p53 and CBP were coexpressed with or without Pdcd4, followed by analysis of the acetylation of lysine 382, which is one of the lysine residues acetylated by p300/CBP. Figure 5b shows that Pdcd4 suppressed the CBP-induced acetylation of lysine 382. Taken together, the experiments illustrated in Figure 5 support the notion that Pdcd4 suppresses p53 activity by diminishing its acetylation.
Pdcd4 knockdown cells show a decreased rate of apoptosis and increased survival after UV irradiation
To explore the biological consequences of the diminished Pdcd4 expression, we first examined the growth rate of the Pdcd4 knockdown clones. We found that these cells grew significantly slower than wild-type HeLa cells (see Supplementary Figure 1 ). This observation is in line with the increased p21(Waf1/Cip1) expression of these cells, which is expected to slow down the cell cycle.
Following DNA damage, cells normally will either undergo a cell-cycle block or initiate programmed cell death. Increased levels of p21(Waf1/Cip1) expression have been shown to favor a cell-cycle block at the expense of apoptosis (Gorospe et al., 1997; Herold et al., 2002; Seoane et al., 2002; Sohn et al., 2006) ; hence, we speculated that the Pdcd4 knockdown cells might be less likely to undergo apoptosis following an apoptotic stimulus. To examine the effect of the deceased Pdcd4 expression on the induction of apoptosis, we UVirradiated Pdcd4 knockdown and control cells and measured the increase of caspase-3 activity as an indicator of the induction of apoptosis. Figure 6 illustrates that the Pdcd4 knockdown cells indeed showed diminished levels of caspase-3 activity after UV irradiation when compared to control cells, indicating that the downregulation of Pdcd4 inhibits apoptosis. This finding suggested that low Pdcd4 expression might favor the survival of cells with damaged DNA that would be eliminated by apoptosis under conditions of normal levels of Pdcd4 expression. If such cells survive and, because of additional events, are able to re-enter the cell cycle, they might contribute to tumorigenesis. To investigate whether the knockdown of Pdcd4 expression increases the survival of cells after DNA damage, we UV-irradiated Pdcd4 knockdown and control cells and allowed surviving cells to form colonies. This experiment (Figure 7 ) clearly showed that colony formation was indeed increased following UV irradiation, thereby providing an explanation for how diminished Pdcd4 expression might contribute to tumor development.
Discussion
Increasing evidence has implicated the Pdcd4 gene as a novel tumor suppressor in the development of several types of human tumors. However, the mechanisms by which Pdcd4 acts to inhibit tumor development are not yet entirely clear. Studies addressing the molecular function of Pdcd4 protein have shown that Pdcd4 is a nuclear-cytoplasmic shuttle protein which interacts with the eukaryotic translation initiation factors eIF4A and eIF4G and acts as an inhibitor of the translation of mRNAs containing stable structures in their 5 0 -UTRs (Go¨ke et al., 2002; Bo¨hm et al., 2003; Yang et al., 2003a Yang et al., , 2004 Palamarchuk et al., 2005) . The N-terminal part of the Pdcd4 protein is able to bind to RNA (Bo¨hm et al., 2003) , raising the possibility that the RNA-binding activity facilitates its role as an inhibitor of translation by directing it to certain, as yet unknown mRNA species. Besides its role as a translational repressor Pdcd4 is also involved in the regulation of transcription. Notably, Pdcd4 has been shown to inhibit the transactivation potential of c-Jun and the downregulation of AP1-responsive promoters (Yang et al., 2001 (Yang et al., , 2003b (Yang et al., , 2006 Bitomsky et al., 2004) . Many of the genes regulated by AP-1 affect in cell motility and tumor cell invasion (Ozanne et al., 2007) , suggesting that decreased Pdcd4 expression might affect the tumor development by altering the mobility and invasiveness of tumor cells.
siRNA-mediated knockdown of Pdcd4 expression N Bitomsky et al Indeed, it has been shown that enforced expression of Pdcd4 in the metastatic colon carcinoma cell line RKO suppresses the invasive phenotype of the cells (Yang et al., 2006) . The work reported here has uncovered and additional function of Pdcd4 as a regulator of the tumorsuppressor p53. We have shown that siRNA-mediated downregulation of Pdcd4 expression causes increased expression of the Cdk-inhibitor p21(Waf1/Cip1), a key mediator of the p53-induced growth arrest following DNA damage and a direct transcriptional target of p53 (El-Deiry et al., 1993) . Furthermore, Pdcd4 diminished the p53-dependent activation of the p21(Waf1/Cip1) promoter as well as of an artificial reporter gene containing p53-binding sites fused to a minimal promoter. Taken together, these data demonstrate that Pdcd4 attenuates the p53-dependent activation of the p21(Waf1/Cip1) gene and that silencing of Pdcd4 causes upregulation of p21(Waf1/Cip1) by alleviating this dampening effect. The inhibitory effect of Pdcd4 appears not to be restricted to the p21(Waf1/Cip1) gene because downregulation of Pdcd4 also affects the expression of certain other p53-regulated genes, as shown by increased Gadd45a and DAP-kinase mRNA levels in the Pdcd4 knockdown cells. How does Pdcd4 act to diminish p53 activity? Although there was a slight increase of the amount of p53 in the stable Pdcd4 knockdown lines (Figure 2a) , the transient knockdown of Pdcd4 did not result in such an increase (Figure 2b) . It therefore appears that the upregulation of p21(Waf1/ Cip1) is no simply due to an increased expression of p53 following Pdcd4 knockdown. That Pdcd4 inhibits the transactivation activity of p53 is also evident from the reporter gene experiments in which the amounts of p53 were not affected (Figure 4) . Our initial data suggest that Pdcd4 interferes with the acetylation of lysine 382 of p53. Acetylation of this and other lysine residues in the C-terminal part of p53 by p300/CBP has been extensively studied and has been identified as one of the regulatory mechanisms controlling the activity of p53 (Gu and Roeder, 1997;  . We do not know at present how Pdcd4 suppresses the acetylation of p53; however, in preliminary work we have observed that Pdcd4 also suppresses the acetylation of other proteins by p300/CBP (for example, B-Myb, unpublished data). This raises the possibility that p300/CBP might be a crucial target of Pdcd4. Taken together, our data demonstrate for the first time a functional link between Pdcd4 and the tumor-suppressor p53, and identify Pdcd4 as a novel regulatory factor in the p53 network.
p21(Waf1/Cip1) has originally been identified as an inhibitor of G 1 cyclin-dependent kinases which mediates the p53-induced growth arrest following DNA damage (El-Deiry et al., 1993; Harper et al., 1993; Xiong et al., 1993) . Our observation that knockdown of the tumorsuppressor Pdcd4 leads to induction of p21(Waf1/Cip1) expression, at first glance appears to be contradictory to the role of p21(Waf1/Cip1) as a negative regulator of cell growth. However, p21(Waf1/Cip1) has recently been recognized as a multifunctional protein that plays additional roles as an inhibitor of apoptosis after DNA damage and as a positive regulator of the cell cycle under certain conditions. There is strong evidence that increased expression of p21(Waf1/Cip1), following DNA damage protects the cells from apoptosis (Gorospe et al., 1997; Herold et al., 2002; Seoane et al., 2002; Sohn et al., 2006) . Thus, p21(Waf1/Cip1) plays a key role in decision of DNA-damaged cells to survive or undergo apoptosis. In accordance with these findings, we have observed that the stable Pdcd4 knockdown cells are more resistant to UV-induced apoptosis than their parental counterparts which show normal levels of Pdcd4 expression. Furthermore, using a colony formation assay, we have demonstrated that the long-term survival after UV irradiation of Pdcd4 knockdown cells is higher than that of the parental cells. Taken together, these observations suggest a model in which low Pdcd4 expression after DNA damage favors the survival of cells which under normal levels of Pdcd4 expression would be eliminated by apoptosis. The observation that the expression of the pro-apoptotic gene Puma was not increased by silencing of Pdcd4 is in line with this notion. If such cells are able to overcome the p21(Waf1/ Cip1)-dependent cell-cycle block and to re-enter the cell cycle they might contribute to tumor development. It has also been shown that proteasome-mediated degradation of p21(Waf1/Cip1) is required for efficient repair of DNA damage elicited by low doses of UV irradiation (Bendjennat et al., 2003) , raising the possibility that the inappropriately high expression of p21(Waf1/Cip1) in Pdcd4 low-expressing cells might result in incomplete repair of DNA damage and, thus, cause mutations under such conditions.
There are also several reports showing that p21(Waf1/ Cip1) may influence cell proliferation also in a positive manner. It has long been known that p21(Waf1/Cip1) functions as an assembly factor in the activation of cyclin D1/Cdk complexes (LaBaer et al., 1997; Sherr and Roberts, 1999) . Overexpression of p21(Waf1/Cip1) has been identified as an early event in the development of pancreatic tumors (Biankin et al., 2001 ). In addition, several studies have shown a marked increase in the level siRNA-mediated knockdown of Pdcd4 expression N Bitomsky et al of p21(Waf1/Cip1) in head and neck tumors (Erber et al., 1997) and in rapidly proliferating gliomas (Jung et al., 1995) . Interestingly, it has been recently shown that Pdcd4 is significantly downregulated in gliomas (Gao et al., 2007) . Studies in human breast cancer cells have shown that p21(Waf1/Cip1) is a positive regulator of proliferation of these cells (Dupont et al., 2003; Fan et al., 2003; Weiss, 2003; Weiss et al., 2003) and increased p21(Waf1/Cip1) expression in breast cancer has been linked to poor prognosis (Yang et al., 2003c) . In summary, we propose that diminished Pdcd4 expression deregulates the normal DNA-damage response thereby favoring the survival of DNA-damaged cells and preventing them from undergoing apoptosis.
Materials and methods

Silencing of Pdcd4
A unique negative control (OR-0030-neg05) siRNA duplex as well as siRNA duplexes used for targeting human Pdcd4 were designed and synthesized by Eurogentec (Liege, Belgium). The siRNA target sequences were GUGUUGGCAGUAUC CUUAG (for siRNA_603) and CAUUCAUACUCUGUG CUGG (for siRNA_1260). Cells were grown in six-well plates to approximately 50-80% confluence and received 1.5 ml fresh growth medium prior to transfection. Then 0.1 nM siRNA was transfected using Metafectene Pro (Biontex Laboratories GmbH, Martinsried, Germany), according to manufacturer's protocols. Cells were harvested 48 h later and the level of knockdown was evaluated by western blotting and PCR. HCT116 cells were transfected in 12-well plates, using HiPerFect (Qiagen, Hilden, Germany) according to the instructions of the supplier and only 10 pmol siRNA per well. Cells were harvested after 48 h and analysed by western blotting. For stable knockdown siRNA pTER-based (van de Wetering et al., 2003) siRNA-expression vectors were constructed using the same target sequences. Plasmids were transfected by calcium-phosphate coprecipitation into HeLa cells and stable transfectants were selected in the presence of 75 mg/ml zeozin. Resulting clones were analysed by western blotting for Pdcd4-expression levels.
Antisera
Human Pdcd4 was detected with a rabbit antiserum raised against a synthetic peptide (MDVENEQILNVNPADC) derived from the N terminus of human Pdcd4. Other antisera were obtained form the following suppliers: p21(Waf1/Cip1) (Upstate Biomol GmbH, Hamburg, Germany), p53 (DO-1; Sigma-Aldrich, Mu¨nchen, Germany and DO-7; Dako Cytomation, Hamburg, Germany), p53 (Ac-Lys-382; Cell Signaling Technology, Frankfurt, Germany), HA tag (HA.11; BabCO, Hiss Diagnostics, Freiburg, Germany); tubulin (D-10; Santa Cruz Biotechnology, Heidelberg, Germany), b-actin (AC-15; Sigma).
Growth curves, caspase-3 assay Growth curves were determined by seeding cells at the desired concentration and counting them at the indicated time points with a hemacytometer. Caspase-3 activity was determined using a commercial assay kit and following the instructions of the supplier (Clontech-Takara Bio Europe, Saint-Germainen-Laye, France). For the colony formation assay, cells were plated using standard tissue culture plates. They were then irradiated with approximately 200 J/m 2 UV light in a tissue culture hood. The cells were then cultivated further for approximately 1 week and colonies were stained with crystal violet.
Northern blotting
Preparation of polyadenylated RNA and northern blotting was performed as described (Burk et al., 1993) . Pdcd4 and ribosomal protein S17 mRNAs were detected with probes described previously (Schlichter et al., 2001) . To detect Gadd45a mRNA, a BglII fragment derived from clone pEGFP-GADD45(3 0 ) (kindly provided by M. Gorospe) and encompassing the 3 0 -UTR of human Gadd45a mRNA was used as probe. A Dap-kinase probe fragment was by PCR using the primers 5 0 -TGCGGCCAACGGAACC-3 0 and 5 0 -GGGTCGGGGCCACAAACAC-3 0 and total cDNA from HeLa cells as target DNA. The fragment was subsequently cloned into pCR2.1-Topo (Invitrogen, Leek, The Netherlands). Puma mRNA was detected by using a NcoI/NheI fragment derived from plasmid pORF5-Puma (InvivoGen, San Diego, CA, USA) and encompassing coding the coding region of human Puma.
Reporter genes and expression vectors
The p21(Waf1/Cip1) luciferase reporter gene p0-luc contains the region from À2326 to þ 16 bp of the human p21(Waf1/ Cip1) gene and was obtained from W El-Deiry (Zeng et al., 1997) . The artificial p53-dependent reporter gene p53-Luc was obtained from Stratagene (Amsterdam, The Netherlands) and contains 14 copies of a p53-binding site upstream of a minimal promoter. The b-galactosidase plasmid pCMVb was obtained from Invitrogen. Expression vectors for wild-type p53 and a GFP-p53 fusion protein were obtained from T. Hofmann and S. Stein. An expression vector for HA-tagged CBP was obtained from R. Eckner. QT6 fibroblasts (Moscovici et al., 1977) were transfected by calcium-phosphate co-precipitation. HeLa cells were transfected using Metafectene Pro-transfection reagent (Biontex) according to the instructions of the supplier. HCT116 cells were transfected with Lipofectamine (Invitrogen) according to the instructions of the supplier. In some experiments, cells were treated with TSA for 12 h at a final concentration of 400 nM. Cells were harvested 48 h after transfection and luciferase and b-galactosidase assays were performed as described previously (Burk et al., 1993) .
